RxDoctor Payments DataLook up a doctor →

Caley Allen

Registered Nurse · Dublin, GANPI 1821619362

Payments from drug & device makers

$7,263in general payments, 2019–2025

Across 340 payments — averaging $21.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$887
  • AstraZeneca$749
  • Merck$583
  • Daiichi Sankyo Inc.$509
  • Regeneron Healthcare Solutions, Inc.$279
  • Novartis$241
  • plus $4K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer43$887
AstraZeneca(2 entities)32$749
Merck25$583
Daiichi Sankyo Inc.27$509
Regeneron Healthcare Solutions, Inc.14$279
Novartis12$241
Dendreon Pharmaceuticals LLC8$227
Bristol Myers Squibb11$225
Genentech USA, Inc.9$181
Lilly USA, LLC9$178
Johnson & Johnson8$177
Incyte Corporation8$171
AVEO Pharmaceuticals, Inc.7$170
Takeda Pharmaceuticals U.S.A., Inc.6$159
Astellas Pharma US Inc7$140
Sanofi6$135
Beone Medicines USA, Inc.5$121
Pharmacosmos Therapeutics Inc.6$120
Amgen7$114
Exelixis Inc.5$113
Karyopharm Therapeutics Inc.5$109
AbbVie5$109
Seagen Inc.4$96
Sobi, Inc5$95
Pharmacyclics LLC, An Abbvie Company1$95
GSK5$94
Array Biopharma Inc6$86
Jazz Pharmaceuticals Inc.4$84
Gilead(2 entities)4$81
Taiho Oncology, Inc.2$80
Eisai Inc.3$64
Mirati Therapeutics, Inc.3$61
E.r. Squibb & Sons, L.L.C.3$61
Geron Corporation3$56
Bayer2$53
Beigene USA, Inc.2$52
Boehringer Ingelheim2$50
Puma Biotechnology, Inc.2$36
Stemline Therapeutics Inc.2$35
Coherus Oncology, Inc.2$34
EMD Serono, Inc.2$33
Novo Nordisk2$32
Biohaven Pharmaceutical Holding Company Ltd.1$24
Tersera Therapeutics LLC1$23
UCB, Inc.1$23
Sunovion Pharmaceuticals Inc.1$21
Pharmaessentia USA Corporation1$21
Nestle Healthcare Nutrition Inc.1$21
Tempus AI, Inc1$20
Immunogen, Inc.1$19
Adaptive Biotechnologies Corporation1$18
Apellis Pharmaceuticals, Inc.1$17
Myriad Genetic Laboratories, Inc.1$16
Iovance Biotherapeutics, Inc.1$14
Sumitomo Pharma America, Inc.1$14
Spectrum Pharmaceuticals Inc.1$14
Genmab U.S., Inc.1$14
Biohaven Pharmaceuticals, Inc.1$12

How this compares

$7,263 in reported general payments places this provider in the 95th percentile of 131 registered nurse providers in Georgia.

See all registered nurse providers in Georgia →

Medicare billing

Part B allowed, 2024
$50,424
Medicare patients
196
Services billed
1,509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other registered nurse in Dublin

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →